228 related articles for article (PubMed ID: 819310)
21. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
22. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
Sheehan KL; Casper RF; Yen SS
Am J Obstet Gynecol; 1979 Nov; 135(6):759-63. PubMed ID: 386801
[TBL] [Abstract][Full Text] [Related]
23. Luteinizing hormone-releasing hormone (LH-RH) as a diagnostic and research tool in gynecologic endocrinology.
Taymor ML; Thompson IE; Berger MJ; Patton W
Am J Obstet Gynecol; 1974 Nov; 120(6):721-32. PubMed ID: 4611213
[TBL] [Abstract][Full Text] [Related]
24. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
Niaraki MA; Moghissi KS; Borin K
Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
[TBL] [Abstract][Full Text] [Related]
25. Importance of progesterone in DNA synthesis of pregnancy-dependent mammary tumors in mice.
Yanai R; Nagasawa H
Int J Cancer; 1976 Sep; 18(3):317-21. PubMed ID: 986372
[TBL] [Abstract][Full Text] [Related]
26. Effects of aging on the hypothalamic-hypophyseal-gonadal axis in female rats.
McPherson JC; Costoff A; Mahesh VB
Fertil Steril; 1977 Dec; 28(12):1365-70. PubMed ID: 201506
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
28. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
Bergquist C; Nillius SJ; Wide L; Lindgren A
Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
[TBL] [Abstract][Full Text] [Related]
29. Plasma norepinephrine during the rat estrous cycle and after progesterone treatment to the ovariectomized estrogen-primed rat.
Nagle CA; Rosner JM
Neuroendocrinology; 1976; 22(1):89-96. PubMed ID: 1035969
[TBL] [Abstract][Full Text] [Related]
30. Luteinizing hormone releasing factor activity in peripheral blood from women during the midcycle luteinizing hormone ovulatory surge.
Malacara JM; Seyler Le J; Reichlin S
J Clin Endocrinol; 1972; 34():271-8. PubMed ID: 12256659
[TBL] [Abstract][Full Text] [Related]
31. Pituitary, ovarian and endometrial effects of progesterone released prematurely during the proliferative phase.
Shumin X; Johannisson E; Landgren BM; Diczfalusy E
Contraception; 1983 Feb; 27(2):177-93. PubMed ID: 6851555
[TBL] [Abstract][Full Text] [Related]
32. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
Schally AV
Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624
[TBL] [Abstract][Full Text] [Related]
33. Production of anti luteinizing hormone releasing factor (LH-RF) serum: immunological application and development of radioimmunoassay.
Shiina M
Nihon Funin Gakkai Zasshi; 1976 Oct; 21(4):12-21. PubMed ID: 12158548
[TBL] [Abstract][Full Text] [Related]
34. Corpus luteum function in lactating women using the Progestasert system.
Abdalla MI; Ibrahim II; Osman MI; Badraoui MH; Askalani H
Contracept Deliv Syst; 1981 Apr; 2(1):127-32. PubMed ID: 12336864
[TBL] [Abstract][Full Text] [Related]
35. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL; Wang CF; Yen SS
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[TBL] [Abstract][Full Text] [Related]
36. The mechanism of action of the copper intrauterine device.
Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
[TBL] [Abstract][Full Text] [Related]
37. Serum prolactin levels in lactating women using progestasert system.
Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
[TBL] [Abstract][Full Text] [Related]
38. The effect of intrauterine progesterone treatment on the endometrial prostaglandin F content in the rabbit.
Scommegna A; Ilekis J; Sotrel G; Auletta FJ
Fertil Steril; 1977 May; 28(5):581-6. PubMed ID: 856639
[TBL] [Abstract][Full Text] [Related]
39. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
40. Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel.
Nilsson CG; Johansson ED; Jackanicz TM; Luukkainen T
Am J Obstet Gynecol; 1975 May; 122(1):90-5. PubMed ID: 1130448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
